Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
European Journal of Human Genetics : EJHG|April 14, 2021
Moving somatic gene editing to the clinic: routes to market access and reimbursement in EuropeTessel Rigter, David Klein, Stephanie S Weinreich, et al.Journal of Community Genetics|October 19, 2020
Neonatal and carrier screening for rare diseases: how innovation challenges screening criteria worldwideMartina C Cornel, Tessel Rigter, Marleen E Jansen, et al.Nederlands Tijdschrift Voor Geneeskunde|September 4, 2024
[Direct-to-consumer genetic tests in the Netherlands: impact on consumers and clinical practice]Danny Bruins, Suzanne M Onstwedder, Mieke M van Haelst, et al.Journal of Medical Internet Research|July 17, 2024
Policy Guidance for Direct-to-Consumer Genetic Testing Services: Framework Development StudySuzanne Maria Onstwedder, Marleen Elizabeth Jansen, Martina Cornelia Cornel, et al.European Journal of Human Genetics : EJHG|February 6, 2026
Public and parent perspectives on genomic sequencing in newborn screening: a scoping reviewSaskia G Smits, Suzanne M Onstwedder, Tessel Rigter, et al.International Journal of Neonatal Screening|April 24, 2026
A Multi-Stakeholder Perspective on Integrating Genomic Sequencing into Newborn Screening: An Interview StudySaskia G Smits, Suzanne M Onstwedder, Tessel Rigter, et al.Frontiers in Genetics|June 10, 2022
Pursuing Public Health Benefit Within National Genomic Initiatives: Learning From Different PoliciesSuzanne M Onstwedder, Marleen E Jansen, Teresa Leonardo Alves, et al.Frontiers in Genetics|February 4, 2026
Incidental genomic findings in large scale research: using the "3-I framework" to reveal policy considerationsSuzanne Maria Onstwedder, Carla Van El, Wendy Rodenburg, et al.Frontiers in Pharmacology|February 13, 2020
DPD Testing Before Treatment With Fluoropyrimidines in the Amsterdam UMCs: An Evaluation of Current Pharmacogenetic PracticeForike K Martens, Daan W Huntjens, Tessel Rigter, et al.BMC Health Services Research|February 18, 2017
Stakeholder perspectives on the implementation of genetic carrier screening in a changing landscapeKim C A Holtkamp, Evelien M Vos, Tessel Rigter, et al.Pageof 4